Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Sage Bionetworks, AZ Enter Cancer Pact

March 18, 2011
Sage Bionetworks and AstraZeneca have entered a collaboration to investigate certain cancers using advanced computational models of disease genetics.   Read More »
Ambrilia, ZBx Enter Licensing Deal

March 18, 2011
Ambrilia has entered into an agreement granting ZBx Corp. an option to acquire exclusive worldwide rights to Ambrilia's PSP-94 reagents and related intellectual property.  Read More »
Pii

March 17, 2011
Gullapalli to run drug delivery tech  Read More »
ARIAD Exercises Ridaforolimus Option

March 17, 2011
ARIAD Pharmaceuticals, Inc. has exercised its option with Merck & Co. to co-promote ridaforolimus, an investigational mTOR inhibitor, in the sarcoma indication, upon approval in the U.S.  Read More »
Laureate Biopharmaceutical Services

March 17, 2011
Ann M. Daus, Ph.D. has been named vice president of Quality at Laureate Biopharmaceutical Services.  Read More »
Epistem, Sanofi Enter Research Pact

March 17, 2011
Epistem has entered into a three-year collaboration with Sanofi-aventis U.S., Inc. for the use of Epistem’s biomarker gene expression profiling and immunohistochemistry technologies.  Read More »
MorphoSys, Boehringer Sign Manufacturing Pact

March 16, 2011
MorphoSys AG and Boehringer Ingelheim have signed a manufacturing agreement for therapeutic antibodies covering the process development and manufacture of additional clinical material for MorphoSys’s MOR208 program and other drug candidates.  Read More »
Akrimax Launches NitroMist

March 16, 2011
Akrimax Pharmaceuticals has introduced NitroMist (Nitroglycerin Lingual Aerosol) 400mcg/spray indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.  Read More »
Almac Adds Walleting for Clinical Trial Supply

March 16, 2011
Almac has invested in two ZED automated inline wallet presses at its Craigavon and Pennsylvania facilities.  Read More »
RegeneRx AMI Trial Placed on Clinical Hold

March 16, 2011
RegeneRx Biopharmaceuticals, Inc. has received a notice from the FDA indicating that, due to non-compliance with cGMP regulations by its contract manufacturer, the company’s Phase II trial of RGN-352 has been placed on clinical hold.  Read More »
Cytovance to Expand Bio-Manufacturing Capabilities

March 15, 2011
Cytovance Biologics has secured financing of $22.5 million from Great Point Partners, LLC to invest in the expansion its biologic manufacturing capabilities in Oklahoma City.  Read More »
Takeda, KINAXO Extend Research Pact

March 15, 2011
KINAXO Biotechnologies GmbH has entered a second collaboration with Takeda Pharmaceutical Co., under which KINAXO will apply its PhosphoScout technology to assist research of Takeda’s drugs under development.   Read More »
Incyte, Novartis Ruxolitinib Trial Shows Promise

March 15, 2011
Incyte Corporation’s COMFORT-II, the second Phase III trial of investigational Janus kinase (JAK) inhibitor, ruxolitinib, has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis.  Read More »
ClinTec International

March 15, 2011
Dr. Stuart Grant has been promoted to associate director of regulatory affairs and medical writing at ClinTec International.   Read More »
Lilly Bids for J&J Animal Health Biz

March 14, 2011
Elanco, Lilly’s animal health division, has made a one-time offer to acquire the animal health business of Janssen Pharmaceutica NV, a Johnson & Johnson company.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: